プロの翻訳者、企業、ウェブページから自由に利用できる翻訳レポジトリまで。
cetrorelix acetate
cetrorelix acetate
最終更新: 2011-10-23
使用頻度: 1
品質:
警告: このアラインメントは正しくない可能性があります。
間違っていると思う場合は削除してください。
0.25 mg cetrorelix (as acetate).
0.25 mg cetrorelix (bħala acetate).
最終更新: 2017-04-26
使用頻度: 1
品質:
the active substance is cetrorelix acetate.
is-sustanza attiva hi cetrorelix acetate.
最終更新: 2017-04-26
使用頻度: 1
品質:
each vial contains 0.25 mg cetrorelix acetate.
kull kunjett fih 0.25 mg ta’ cetrorelix acetate.
最終更新: 2017-04-26
使用頻度: 1
品質:
each vial contains 0.25 mg cetrorelix (as acetate).
kull kunjett fih 0.25 mg ta’ cetrorelix (bħala acetate).
最終更新: 2017-04-26
使用頻度: 1
品質:
cetrotide 0.25 mg powder for solution for injection cetrorelix
cetrotide 0.25 mg trab għal soluzzjoni għall-injezzjoni cetrorelix
最終更新: 2017-04-26
使用頻度: 1
品質:
cetrotide contains a medicine called ‘cetrorelix acetate’.
cetrotide fih mediċina msejħa ‘cetrorelix acetate’.
最終更新: 2017-04-26
使用頻度: 1
品質:
cetrotide is a medicine that contains the active substance cetrorelix.
cetrotide huwa mediċina li fiha s-sustanza attiva cetrorelix.
最終更新: 2017-04-26
使用頻度: 1
品質:
cetrorelix competes with the binding of endogenous lhrh to these receptors.
cetrorelix jikkompeti ma’ l- għaqda ta’ lhrh endoġeni għal dawn ir-riċetturi.
最終更新: 2017-04-26
使用頻度: 3
品質:
cetrorelix is a luteinising hormone releasing hormone (lhrh) antagonist.
cetrorelix hu antagonist tal-ormon li jistimula l-produzzjoni tal-ormon ta’ lutejinazzazzjoni (lhrh).
最終更新: 2017-04-26
使用頻度: 1
品質:
the absolute bioavailability of cetrorelix after subcutaneous administration is about 85%.
il-mod assolut ta’ kif jinfirex fil-ġisem cetrorelix mogħti taħt il-ġilda hu ta’ madwar 85%.
最終更新: 2017-04-26
使用頻度: 1
品質:
cetrorelix showed no mutagenic or clastogenic potential in gene and chromosome mutation assays.
cetrorelix ma wera l-ebda potenzjal mutaġeniku jew klastoġeniku f’analiżi tal-ġeni u ta’ mutazzjoni ta’ kromożomi.
最終更新: 2017-04-26
使用頻度: 3
品質:
this ensures a delivery to the patient of a dose of at least 0.23 mg cetrorelix.
dan jassigura li l- pazjent jingħata doża ta ’ mill- anqas 0. 23 mg cetrorelix.
最終更新: 2012-04-10
使用頻度: 4
品質:
after reconstitution with the solvent provided, the concentration of cetrorelix is 1 mg/ ml.
wara t- taħlita mas- solvent provdut, il- konċentrazzjoni ta ’ cetrorelix hi ta ’ 1 mg/ ml.
最終更新: 2012-04-10
使用頻度: 4
品質:
following a single dose of 3 mg of cetrorelix a duration of action of at least 4 days has been evaluated.
wara doża waħda ta ’ 3mg cetrorelix, kien hemm perjodu ta ’ azzjoni ta ’ mill - inqas erbat ijiem.
最終更新: 2012-04-10
使用頻度: 4
品質:
studies in animals have indicated that cetrorelix exerts a dose related influence on fertility, reproductive performance and pregnancy.
studji fuq annimali indikaw li cetrorelix jeżerċita influwenza fuq il-fertilità, kapaċità riproduttiva u tqala skont kemm tkun qawwija d-doża li tingħata.
最終更新: 2017-04-26
使用頻度: 1
品質:
in animals as well as in humans, the antagonistic hormonal effects of cetrorelix were fully reversible after termination of treatment.
fl-annimali kif ukoll fil-bnedmin, l-effetti ormonali antagonistiċi ta’ cetrorelix kienu kompletament riversibbli wara t-tmiem tal-kura.
最終更新: 2017-04-26
使用頻度: 5
品質:
no target organ toxicity could be observed from acute, subacute and chronic toxicity studies in rats and dogs following subcutaneous administration of cetrorelix.
l-ebda effett tossiku fl-organi li fuqhom jaħdem cetrorelix ma kien osservat minn studji dwar effett tossiku akut, bejn akut u kroniku, u kroniku fuq ġrieden u klieb wara amministrazzjoni għal taħt il- ġilda ta’ cetrorelix.
最終更新: 2017-04-26
使用頻度: 3
品質:
the subcutaneous administration of single doses (0.25 mg to 3 mg cetrorelix) and also daily dosing over 14 days show linear kinetics.
l-amministrazzjoni taħt il-ġilda ta’ doża waħda (0.25 mg sa 3 mg cetrorelix) u ta’ doża kuljum għal 14-il ġurnata turi kinetika linejari.
最終更新: 2017-04-26
使用頻度: 1
品質:
in acute toxicity studies in rodents non-specific toxic symptoms were observed after intraperitoneal administration of cetrorelix doses more than 200 times higher than the pharmacologically effective dose after subcutaneous administration.
fi studji dwar effett tossiku akut fuq annimali gerriema kienu osservati sintomi tossiċi mhux speċifiċi wara l-amministrazzjoni ġol-peritonew ta’ dożi ta’ cetrorelix ta’ 200 darba aktar mid-doża farmakoloġikament effettiva wara l-amministrazzjoni taħt il-ġilda.
最終更新: 2017-04-26
使用頻度: 1
品質: